9-Phenyl-9H-Carbazol-3-Ylboronic Acid

We are 9-Phenyl-9H-Carbazol-3-Ylboronic Acid CAS:854952-58-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:9-Phenyl-9H-Carbazol-3-Ylboronic Acid
CAS.NO:854952-58-2
Synonyms:(9-phenylcarbazol-3-yl)boronic acid
Molecular Formula:C18H14BNO2
Molecular Weight:287.12000
 
Physical and Chemical Properties:
Density:1.2
Boiling point:466ºC
Flash point:235.6ºC
 
Specification:
Appearance:Off-white powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates

9-Phenyl-9H-Carbazol-3-Ylboronic Acid


Related News: Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.4'-ethynyl-2-fluoro-2'-deoxyadenosine CAS:865363-93-5 Due to the cyclic nature of the upstream chemical products of the API, it is expected that the impact of price fluctuations of raw materials on the performance of API companies is unavoidable, but companies with thick product lines and the ability to produce intermediates are expected to minimize the upstream price impact.(S)-4-Chloro-3-hydroxybutyronitrile CAS:127913-44-4 Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.40789-98-8 Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).

Related Products
Product Name
1,3-bis(4′-Aminophenoxyl)benzene View Details
3,4-dimethylbenzoic acid View Details
N-(3-chloropropyl)dibutylamine View Details
4-AMINO-2-FLUOROBENZOIC ACID manufacturer 2,7-dibromo-9,9-diphenylfluorene manufacturer 2,5-Diamino-4,6-dihydroxypyrimidine hydrochloride manufacturer 4-Nitrophenyl isocyanate manufacturer Triphenylmethanol manufacturer